±×·¹À̺꽺º´¿¡¼­ ¸ÞƼ¸¶Á¹ Åõ¿© ÈÄ ¹ß»ýÇÑ ¹«°ú¸³±¸Áõ°ú ±Þ¼ºÃæ¼ö¿°
A Case of Acute Appendicitis in a Patient with Methimazole-Induced Agranulocytosis

´ëÇѳ»°úÇÐȸÁö 2014³â 86±Ç 2È£ p.232 ~ p.236

È«¾Æ¶÷(Hong A-Ram) - ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
¹Ú°æ¼±(Park Kyung-Seon) - ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
Á¶¿ë¼÷(Jo Yong-Suk) - ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
¹ÚµµÁØ(Park Do-Joon) - ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
¹Ú¿µÁÖ(Park Young-Joo) - ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
±èÁ¤Èñ(Kim Jung-Hee) - ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç

Abstract

¹«°ú¸³±¸ÁõÀº ¸ÞƼ¸¶Á¹À» º¹¿ëÇϴ ȯÀÚ¿¡¼­ µå¹°°Ô ¹ß»ýÇϳª Ä¡¸íÀûÀÎ ºÎÀÛ¿ëÀ¸·Î¼­ ´ëºÎºÐ »ó±âµµ °¨¿°ÀÇ ÇüÅ·Π¹ßÇöÇÑ´Ù. ±×·¹À̺꽺º´À¸·Î ¸ÞƼ¸¶Á¹À» º¹¿ëÇÏ´ø ȯÀÚ¿¡¼­ ¹«°ú¸³±¸ÁõÀÌ ±Þ¼ºÃæ¼ö¿°À¸·Î ¹ßÇöÇÑ Áõ·Ê´Â º¸°íµÈ ¹Ù ¾ø´Ù. º» ÀúÀÚµéÀº ±×·¹À̺꽺º´À¸·Î ¸ÞƼ¸¶Á¹À» º¹¿ëÇÏ´ø Áß ¹ß»ýÇÑ ¹«°ú¸³±¸ÁõÀÌ µå¹°°Ô ±Þ¼ºÃæ¼ö¿°À¸·Î ¹ßÇöÇÑ È¯ÀÚ¿¡¼­ ÀûÀýÇÑ ³»°úÀû Ä¡·á ¹× ¼ö¼úÀû Ä¡·á ÈÄ ¾çÈ£ÇÑ °æ°ú¸¦ È®ÀÎÇÏ¿´±â¿¡ ¹®Çå°íÂû°ú ÇÔ²² º¸°íÇÏ´Â ¹ÙÀÌ´Ù.
Agranulocytosis is a rare, but life-threatening, adverse effect of methimazole, which usually manifests as an upper respiratory infection. Agranulocytosis together with acute appendicitis is especially rare in patients with Graves¡¯ disease taking methimazole. A 44-year-old woman presented to our hospital with abdominal pain and a fever. She had been taking methimazole and propranolol for Graves¡¯ disease for the previous 8 weeks. Her symptoms were compatible with acute appendicitis. Computed tomography of the abdomen revealed acute appendicitis with impending rupture. However, the circulating absolute neutrophil count was 10/mm3. We managed her with antibiotics and granulocyte colony stimulating factor rather than with emergency surgery. The thyrotoxicosis was treated with intravenous contrast medium while fasting, followed by Lugol¡¯s solution and lithium. After recovering from the neutropenia, she underwent a total thyroidectomy combined with an appendectomy. Here, we report a patient with Graves¡¯ disease who developed methimazole-induced agranulocytosis presenting as acute appendicitis.

Ű¿öµå

±×·¹À̺꽺º´, ¹«°ú¸³±¸Áõ, ±Þ¼ºÃæ¼ö¿°
Graves¡¯ disease, Agranulocytosis, Acute appendicitis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå